Pfizer Inc has agreed to spin off its off-patent branded drugs business and combine it with generic drugmaker Mylan NV , a move that leaves Pfizer with its more profitable innovative drugs, including cancer treatment Ibrance and pneumonia vaccine Prevnar. | Video
AstraZeneca Plc raised its product sales forecast for 2019 on Thursday after second-quarter results beat analysts' expectations, thanks to strong sales from cancer medicines and emerging markets, especially China.
July 24 GlaxoSmithKline beat second
quarter profit expectations with the help of strong demand for
its shingles vaccine, prompting the British drugmaker to
forecast a smaller fall in profit this year than originally
June 25 Drugmaker AbbVie Inc said on
Tuesday it would acquire Allergan Plc for about $63
billion, giving AbbVie control over the lucrative wrinkle
treatment Botox and buying time to seek new growth before its
blockbuster arthritis treatment Humira loses U.S. patent
(Reuters Health) - Pregnant women with migraine headaches are more likely to develop complications, and their babies are at higher risk for complications early after birth, too, a large study from Denmark suggests.
Spending time in the sun without protection increases the risk of melanoma, but the potentially deadly skin cancer can occur even on sites with minimal sun exposure, doctors warn.
A recent study suggests that light physical activity may help stave off signs of aging in the brain.
GlaxoSmithKline forecast on Wednesday that 2019 sales of its shingles vaccine would be more than 1 billion pounds ($1.3 billion) but the British drugmaker's shares slipped on concerns about its pharmaceutical business and free cash flow.
(Reuters Health) - Unborn babies are at higher risk of heart defects not just when mothers smoke, but when fathers smoke, too, a new study suggests.
(Reuters Health) - One in three U.S. patients with a cancer diagnosis has recently used non-standard therapies to manage their disease - but many haven't told their doctors, survey data suggest.